Patents by Inventor Felix Ellett

Felix Ellett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microfluidic neutrophil assays and systems for disease detection
    Patent number: 11130132
    Abstract: The disclosure relates to microfluidic devices and methods of use thereof for monitoring the directionality, velocity, and migration persistence of neutrophils or other cells in the absence of chemical gradients for the purposes of detecting and quantifying abnormal neutrophil motility phenotypes, using low sample volumes and with minimal activation of the neutrophils. The devices and methods can be used to diagnose sepsis in subjects suspected of having sepsis or at risk of developing sepsis. The devices and methods can also be used to monitor the responses of patients to sepsis therapies.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: September 28, 2021
    Assignee: The General Hospital Corporation
    Inventors: Daniel Irimia, Felix Ellett, Julianne Jorgensen
  • MICROFLUIDIC NEUTROPHIL ASSAYS AND SYSTEMS FOR DISEASE DETECTION
    Publication number: 20190143326
    Abstract: The disclosure relates to microfluidic devices and methods of use thereof for monitoring the directionality, velocity, and migration persistence of neutrophils or other cells in the absence of chemical gradients for the purposes of detecting and quantifying abnormal neutrophil motility phenotypes, using low sample volumes and with minimal activation of the neutrophils. The devices and methods can be used to diagnose sepsis in subjects suspected of having sepsis or at risk of developing sepsis. The devices and methods can also be used to monitor the responses of patients to sepsis therapies.
    Type: Application
    Filed: May 8, 2017
    Publication date: May 16, 2019
    Inventors: Daniel Irimia, Felix Ellett, Julianne Jorgensen